Arthritis Research & Therapy

official impact factor 4.36

Email this article to a friend

Scar wars: is TGFβ the phantom menace in scleroderma?

Andrew Leask

Arthritis Research & Therapy 2006, 8:213 doi:10.1186/ar1976

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.